AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

GLIMEPIRIDE+METFORMIN HYDROCHLORIDE

11 registrations across 5 African markets— 8 active

Markets with GLIMEPIRIDE+METFORMIN HYDROCHLORIDE

Recent registrations

Brand / ProductMarketHolderStatusExpires
GLIMEPIRIDE / METFORMIN HYDROCHLORIDE IMPACT
TABLET, COATED; ORAL
🇿🇼ZimbabweSANOFI - AVENTISactiveFeb 2031
ILET B1 TABLETS (Each uncoated tablet contains Glimepiride/Metformin Hydrochloride 1mg/500mg)🇬🇭GhanaactiveFeb 2030
ILET B2 TABLETS (Each uncoated tablet contains Glimepiride/Metformin Hydrochloride 2mg/500mg)🇬🇭GhanaactiveFeb 2030
ILET B1 TABLETS (Each uncoated tablet contains Glimepiride/Metformin Hydrochloride 1mg/500mg)🇬🇭GhanaactiveFeb 2030
ILET B2 TABLETS (Each uncoated tablet contains Glimepiride/Metformin Hydrochloride 2mg/500mg)🇬🇭GhanaactiveFeb 2030
Amaryl-M 2mg/500mg tablets
Tablet Uncoated
🇿🇲ZambiaSanofi-Aventis South Africa (pty) ltdactiveMay 2029
SHAGLI M🇬🇭GhanaactiveJul 2027
SHAGLI M🇬🇭GhanaactiveJul 2027
RANOPHAGE-G2 2MG/500MG EXTENDED RELEASE TABLETS
EXTENDED RELEASE TABLETS
🇲🇼MalawiexpiredMar 2023
RANOPHAGE~G1 1MG/500MG EXTENDED RELEASE TABLETS
EXTENDED RELEASE TABLETS
🇲🇼MalawiexpiredMar 2023
AMARYL M 2MG/500MG COMPRIME PELLICULE BOITE DE 30🇨🇮Côte d'IvoireSANOFI-AVENTIS FRANCEexpiredOct 2019

GLIMEPIRIDE+METFORMIN HYDROCHLORIDE in Africa — Regulatory Overview

GLIMEPIRIDE+METFORMIN HYDROCHLORIDE is registered across 5 African markets with 11 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Ghana, Malawi, Côte d'Ivoire, Zambia and 1 more. AfricaRegulatory refreshes this data daily from official government sources.

Of the 11 registrations, 8 (73%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.